Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$2.20 USD
-0.34 (-13.39%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $2.27 +0.07 (3.18%) 5:14 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Price, Consensus and EPS Surprise
APDN 2.20 -0.34(-13.39%)
Will APDN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APDN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for APDN
Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions
WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch
APDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Applied DNA Sciences (APDN) Tops Q3 Earnings Estimates
Axon Enterprise (AXON) Q2 Earnings and Revenues Top Estimates
Ball (BALL) Q2 Earnings Beat Estimates
Other News for APDN
Tonix stock jumps on collaboration for mpox vaccine candidate
Trinity stock soars post-market on raised guidance, increased capacity
Labcorp considering ramping up mpox testing capacity: report
Wall Street Breakfast: What Moved Markets
Applied DNA submits validation package to NYS Department of Health